These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

244 related items for PubMed ID: 2527073

  • 1. Interaction of potassium channel openers and blockers in canine atrial muscle.
    Yanagisawa T, Hashimoto H, Taira N.
    Br J Pharmacol; 1989 Jul; 97(3):753-62. PubMed ID: 2527073
    [Abstract] [Full Text] [Related]

  • 2. The negative inotropic effect of nicorandil is independent of cyclic GMP changes: a comparison with pinacidil and cromakalim in canine atrial muscle.
    Yanagisawa T, Hashimoto H, Taira N.
    Br J Pharmacol; 1988 Oct; 95(2):393-8. PubMed ID: 2852521
    [Abstract] [Full Text] [Related]

  • 3. Specific antagonism by glibenclamide of negative inotropic effects of potassium channel openers in canine atrial muscle.
    Satoh E, Yanagisawa T, Taira N.
    Jpn J Pharmacol; 1990 Oct; 54(2):133-41. PubMed ID: 2150209
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Comparative electrophysiological and mechanical actions of ATP-sensitive potassium channel openers in canine Purkinje fibers.
    Satoh H.
    Gen Pharmacol; 1993 May; 24(3):565-75. PubMed ID: 8365637
    [Abstract] [Full Text] [Related]

  • 6. Comparative effects of K+ channel blockade on the vasorelaxant activity of cromakalim, pinacidil and nicorandil.
    Wilson C, Coldwell MC, Howlett DR, Cooper SM, Hamilton TC.
    Eur J Pharmacol; 1988 Aug 02; 152(3):331-9. PubMed ID: 2851450
    [Abstract] [Full Text] [Related]

  • 7. Effect of three novel K+ channel openers, cromakalim, pinacidil and nicorandil on allergic reaction and experimental asthma.
    Nagai H, Kitagaki K, Goto S, Suda H, Koda A.
    Jpn J Pharmacol; 1991 May 02; 56(1):13-21. PubMed ID: 1831870
    [Abstract] [Full Text] [Related]

  • 8. Glibenclamide is a competitive antagonist of cromakalim, pinacidil and RP 49356 in guinea-pig pulmonary artery.
    Eltze M.
    Eur J Pharmacol; 1989 Jun 20; 165(2-3):231-9. PubMed ID: 2528466
    [Abstract] [Full Text] [Related]

  • 9. Differential antagonism by glibenclamide of the relaxant effects of cromakalim, pinacidil and nicorandil on canine large coronary arteries.
    Satoh K, Yamada H, Taira N.
    Naunyn Schmiedebergs Arch Pharmacol; 1991 Jan 20; 343(1):76-82. PubMed ID: 1827660
    [Abstract] [Full Text] [Related]

  • 10. Effects of potassium channel blockers on the negative inotropic responses induced by cromakalim and pinacidil in guinea pig atrium.
    Lau WM.
    Pharmacology; 1992 Jan 20; 45(1):9-16. PubMed ID: 1508969
    [Abstract] [Full Text] [Related]

  • 11. [The vasospasmolytic effects of nicorandil, cromakalim and pinacidil on 3,4-diaminopyridine-induced phasic contractions in canine coronary arteries as an experimental vasospasm model].
    Kamijo T, Tomaru T, Miwa A, Nakamura F, Kido H, Sugimoto T, Uchida Y.
    Nihon Yakurigaku Zasshi; 1992 Oct 20; 100(4):317-27. PubMed ID: 1446882
    [Abstract] [Full Text] [Related]

  • 12. Effects of ATP-sensitive K+ channel openers on pacemaker activity in isolated single rabbit sino-atrial node cells.
    Satoh H.
    J Cardiovasc Pharmacol; 1993 Dec 20; 22(6):863-8. PubMed ID: 7509906
    [Abstract] [Full Text] [Related]

  • 13. Nicorandil increases coronary blood flow predominantly by K-channel opening mechanism.
    Yoneyama F, Satoh K, Taira N.
    Cardiovasc Drugs Ther; 1990 Aug 20; 4(4):1119-26. PubMed ID: 2150593
    [Abstract] [Full Text] [Related]

  • 14. Analysis of cromakalim-, pinacidil-, and nicorandil-induced relaxation of the 5-hydroxytryptamine precontracted rat isolated basilar artery.
    Ksoll E, Parsons AA, Mackert JR, Schilling L, Wahl M.
    Naunyn Schmiedebergs Arch Pharmacol; 1991 Apr 20; 343(4):377-83. PubMed ID: 1830131
    [Abstract] [Full Text] [Related]

  • 15. Hyperpolarization induced by K+ channel openers inhibits Ca2+ influx and Ca2+ release in coronary artery.
    Yanagisawa T, Yamagishi T, Okada Y.
    Cardiovasc Drugs Ther; 1993 Aug 20; 7 Suppl 3():565-74. PubMed ID: 8251426
    [Abstract] [Full Text] [Related]

  • 16. K+ channel blocking and anti-muscarinic effects of a novel piperazine derivative, INO 2628, on the isolated dog atrium.
    Furukawa Y, Akahane K, Ogiwara Y, Chiba S.
    Eur J Pharmacol; 1991 Feb 07; 193(2):217-22. PubMed ID: 1828769
    [Abstract] [Full Text] [Related]

  • 17. Pharmacology and structure-activity relationships for KATP modulators: tissue-selective KATP openers.
    Atwal KS.
    J Cardiovasc Pharmacol; 1994 Feb 07; 24 Suppl 4():S12-7. PubMed ID: 7898103
    [Abstract] [Full Text] [Related]

  • 18. Specific but differential antagonism by glibenclamide of the vasodepressor effects of cromakalim and nicorandil in spinally-anaesthetized dogs.
    Yamada H, Yoneyama F, Satoh K, Taira N.
    Br J Pharmacol; 1990 Jul 07; 100(3):413-6. PubMed ID: 2143956
    [Abstract] [Full Text] [Related]

  • 19. Effects of several potassium channel openers and glibenclamide on the uterus of the rat.
    Piper I, Minshall E, Downing SJ, Hollingsworth M, Sadraei H.
    Br J Pharmacol; 1990 Dec 07; 101(4):901-7. PubMed ID: 2128195
    [Abstract] [Full Text] [Related]

  • 20. Effects of cromakalim, pinacidil and nicorandil on cardiac refractoriness and arterial pressure in open-chest dogs.
    Spinelli W, Follmer C, Parsons R, Colatsky T.
    Eur J Pharmacol; 1990 Apr 25; 179(3):243-52. PubMed ID: 2142089
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.